Omnicell, Inc. (NASDAQ: OMCL) announces results for its first quarter ended March 31, 2021.
Represents Omnicell’s 148th Long-Term Partnership with a Top 300 US Health System
Omnicell Division Will Leverage Twilio's Cloud Communications Platform to Power New Personalized Communications Capabilities
Adoption of Technology-Enabled Services and Dispensing Solutions Supports Autonomous Pharmacy Vision
Expanded Partnership Demonstrates Value of Technology-Enabled Services and Autonomous Pharmacy Vision
Ms. Mellon will lead human resources functions, employee environments, and internal communications for Omnicell’s global operations.
Omnicell, Inc. (NASDAQ: OMCL) announces results for its fiscal year and fourth quarter ended December 31, 2020.
Partnership to Optimize Enterprise Medication Inventory Management Across the Health System
Company Expects to Exceed Previously Announced Guidance Across All Key Metrics; Provides Full Year 2021 Guidance and Updates Long-Term Targets
CareScheduler Automates Vaccine Scheduling, Consent Collection, Registry Reporting and Patient Outreach; Enables Pharmacies to Efficiently Administer COVID-19 Vaccine
Omnicell announced its intent to enter a new partnership with Guy’s and St Thomas’ NHS Foundation Trust, London to develop technology-enabled inventory optimization and intelligence services.
Owensboro Health, a long-term sole source partner, will expand their medication management automation platform to central pharmacy operations with Omnicell’s Central Pharmacy Dispensing Service.
EnlivenHealth™ launches CareScheduler solution to enable pharmacies to provide hands-free scheduling, consent and registry reporting for COVID-19 vaccine, and announces results of COVID-19 vaccine survey
Omnicell's Winter 2020 release delivers innovation to support the Autonomous Pharmacy to zero-error medication management.
Omnicell will provide Allegheny Health Network (AHN) with central pharmacy dispensing and medication management solutions at the point of care across the network’s 13 hospital locations in western Pennsylvania.
Omnicell, Inc. (NASDAQ: OMCL) announces results for its third quarter ended September 30, 2020.